Higher Education

NDA for UK Universities: Protecting Research Collaborations, KTP Partnerships and Spin-Out Discussions

UK universities and academic institutions share commercially sensitive research data, intellectual property, spin-out valuations and technology transfer information with industry partners, investors and collaborators before formal agreements are in place. This guide explains when a university NDA is needed, what it must cover, and which NDASafe template fits each type of academic-industry relationship.

By Richard Wood, Founder7 min readUpdated 26 June 2026Last reviewed 26 June 2026NDAuniversityhigher educationresearch collaboration

UK universities and academic institutions operate at the intersection of publicly funded research and commercial innovation. They share pre-publication research data, patent-pending technology, clinical trial results, prototype performance data and spin-out valuations with industry partners, investors, technology transfer organisations and potential licensees throughout the collaboration and commercialisation process. At every stage before a formal collaboration agreement, licensing deal or spin-out investment agreement is executed, an NDA is the mechanism for ensuring that the commercially sensitive information shared in that pre-contract phase is protected by binding contractual obligations.

This is general information, not legal advice

NDASafe is a document preparation service, not a law firm. Our templates are legally reviewed against applicable UK law at the point of release, but every situation is different. Where significant value, unusual risk or a cross-border element is involved, take independent legal advice before you sign.

When UK universities need an NDA

An NDA is appropriate at the following stages in a university’s research and commercialisation activity:

  • Pre-formal-agreement industry collaborations: before a university research team shares unpublished data, experimental results or technical capabilities with an industry partner who is assessing whether to fund or participate in a formal collaboration.
  • Technology transfer and licensing discussions: before the university technology transfer office shares details of a patented or patent-pending technology with a potential licensee, commercialisation partner or technology company evaluating a licence.
  • Spin-out investor discussions: before a university spin-out discloses its founding technology, laboratory performance data, clinical evidence, financial projections or commercial strategy to angel investors, venture capital firms or corporate venture partners.
  • KTP scoping and pre-application discussions: before a university and a KTP business partner discuss the proposed project scope, feasibility and commercial objectives during the period before the KTP agreement is executed.
  • Contract research negotiations: before a university research group receives a commercial research brief from an industry partner, including the problem statement, proprietary data or competitive context that the industry partner considers confidential.
  • Visiting researcher and external collaborator access: before a visiting academic, doctoral student, postdoctoral researcher or external consultant is granted access to unpublished research data, pre-patent IP or confidential industry partner information.
  • Clinical and health data research partnerships: before a university research team receives access to NHS, industry or commercial clinical data for a research project, before any formal data sharing agreement is executed.

What a UK university NDA must cover

A university NDA must address the specific IP and publication landscape of academic-industry relationships:

  • Pre-publication research and data: the confidential information definition must expressly cover unpublished research data, experimental results, pre-publication manuscripts, datasets and laboratory findings — not just commercially produced documents.
  • Patent preservation: an express prohibition on the industry partner filing any patent application based on or derived from the disclosed research or invention disclosures, and a confirmation that the disclosure does not constitute a grant of any licence in the university’s IP.
  • Background IP protection: confirmation that the NDA does not transfer any rights in the university’s pre-existing background IP, and that the receiving party’s right to use the disclosed information is limited to the stated evaluation or research purpose.
  • Academic publication carve-out: a structured carve-out permitting the university to publish peer-reviewed research results and comply with UKRI open-access mandates, subject to prior notice to the industry partner and a short review and delay period.
  • Permitted disclosees mechanism: a mechanism for extending the confidentiality obligations to researchers, students, postdoctoral staff and visiting academics who need access to the information, without requiring each to sign a separate agreement.
  • Duration matched to the research lifecycle: confidentiality obligations should last for the duration of the pre-formal-agreement discussions plus two to five years — reflecting the time required to commercialise research findings — with indefinite survival for information that qualifies as a trade secret.

Which NDASafe template to use

The right template depends on the structure of the university or spin-out relationship:

  • Mutual NDA (£29): the default for most university-industry research collaborations where both parties share sensitive information. The university discloses research data and the industry partner discloses proprietary commercial information about the problem, its data and its competitive context.
  • One-Way NDA, Disclosing (£29): for spin-out investor pitches and technology licensing discussions where only the university or spin-out is disclosing technology, IP and commercial data, without receiving equivalent confidential information from the investor or licensee.
  • NDA with IP Assignment (£29): where the industry partner is commissioning the university to create a specific research output, software tool or dataset and the partner must own the resulting IP from creation. The NDA with IP Assignment establishes both the pre-commission confidentiality framework and the IP ownership structure.
  • Freelancer NDA (£29): for individual academics, researchers and postdoctoral staff engaged by industry partners as external consultants. Covers pre-engagement confidentiality, IP assignment of consultancy outputs, and IR35 acknowledgement.
  • Complete NDA Bundle (£79): all eight NDA variants. Suited to university technology transfer offices managing investor pitches, licensing discussions, collaboration agreements, contract research briefs and individual researcher consultancy across multiple industry relationships.
UK university and research NDA templates — legally reviewed, instant download

NDASafe's NDA templates are editable Word documents appropriate for UK universities, research institutions, technology transfer offices and spin-out companies. Single template £29. Complete bundle (all 8 variants) £79. Delivered instantly as an editable .docx file.

Step by step

  1. 1
    Sign before sharing any pre-publication research data or unpublished IP

    The highest-risk point in a university-industry relationship is the pre-formal-agreement stage — when the university is sharing unpublished research data, laboratory results, prototype specifications, clinical data or pre-patent invention disclosures to explore the commercial potential of a collaboration. At this stage, the information has maximum commercial value precisely because it has not yet been published. An NDA must be in place before any substantive technical information is shared — before the first technical briefing, before any data room or data sharing arrangement is established, and before any invention disclosure document is shared with a potential licensee or investor. Universities that routinely share preliminary research findings at networking events, conferences or industry briefings without NDAs risk both patent invalidation and commercial misappropriation of their research.

  2. 2
    Address IP ownership, background IP and foreground IP explicitly

    University NDAs must navigate a more complex IP landscape than commercial NDAs. The NDA should clearly distinguish between: Background IP (pre-existing IP owned by the university, the industry partner or a third party such as a research council funder) — the NDA should confirm that it does not transfer any rights in background IP; Foreground IP (new IP created during the collaboration) — ownership of foreground IP is determined by the collaboration agreement and typically negotiated separately from the NDA; Disclosed IP (pre-existing university IP disclosed to the industry partner for evaluation purposes) — the NDA must prohibit the industry partner from filing any patent, design right or trade mark based on or derived from the disclosed IP without the university’s written consent. The Lambert Toolkit model agreements, used by many UK universities for industry collaboration, address foreground IP in the formal agreement rather than the NDA — but the pre-Lambert NDA must expressly preserve the university’s rights in its disclosed background IP.

  3. 3
    Include specific carve-outs for academic publication and open-access obligations

    Universities have obligations to publish research results that commercial companies do not. Researchers are required to publish peer-reviewed findings; UKRI-funded projects have open-access publication mandates; doctoral theses are typically deposited in institutional repositories. A university NDA must include a clear academic publication carve-out: the confidentiality obligations do not prevent the university from publishing peer-reviewed research results, depositing doctoral theses, or complying with UKRI open-access requirements — but the industry partner must be given prior notice of any intended publication so that it can: review the manuscript for inadvertent disclosure of the partner’s confidential information; assess whether a patent application should be filed before the publication date (a 12-month priority period exists under UK and European patent law from the UK filing date); and request a short publication delay (typically 30 to 90 days) to allow a provisional patent application to be filed. Without this carve-out, the NDA risks placing the university in breach for complying with its academic and funding obligations.

  4. 4
    Cover student, researcher and visiting academic access

    University research environments involve a broader range of individuals who may access confidential information than a typical commercial NDA anticipates: PhD students, postdoctoral researchers, visiting academics, research assistants, undergraduate project students, and external collaborators all form part of the research team at different points. The NDA should: define ‘permitted disclosees’ to include researchers, students and employees who need access to the confidential information for the specified research purpose; require the university to ensure that each permitted disclosee is bound by confidentiality obligations at least as stringent as those in the NDA; and require the university to notify the industry partner of any permitted disclosee who becomes aware of a material breach. For KTP partnerships, the KTP associate (who typically works embedded within the business partner’s organisation) should be covered by the NDA as well as the KTP agreement to ensure pre-agreement confidentiality is maintained during the scoping phase.

  5. 5
    Choose the right NDASafe template for the academic-industry relationship

    For a university-industry research collaboration where both parties share commercially sensitive information — the university discloses research data and the industry partner discloses proprietary commercial information about the problem to be solved — use the Mutual NDA. For investor or licensee discussions where only the university spin-out is disclosing technology, research data or IP — use the One-Way NDA, Disclosing. Where the industry partner is commissioning the university to create bespoke software, a dataset or a specific research output and the partner must own the resulting IP — use the NDA with IP Assignment to establish confidentiality and IP ownership before the formal commission agreement is drafted. For individual academics and researchers engaged as external consultants by industry partners — the Freelancer NDA provides appropriate protection for the pre-engagement confidentiality and IP assignment phase. For universities and technology transfer offices managing multiple industry relationships simultaneously — the Complete NDA Bundle provides all eight variants for different relationship types.

Frequently asked questions

Do UK universities need an NDA before sharing research data with industry partners?

Yes. A university that shares unpublished research data, experimental results, clinical trial data, proprietary datasets or pre-patent technical information with an industry partner before a formal collaboration agreement is executed has made a disclosure of confidential information. Without an NDA, the industry partner has no contractual obligation to keep that information confidential, refrain from using it for competitive purposes, or preserve the university's ability to file a patent. Under the Patents Act 1977, a prior public disclosure — which can include an uncontrolled disclosure to a commercial entity — may destroy novelty and prevent the university from filing a valid UK or European patent application. An NDA signed before any pre-publication research data is shared with an industry partner is essential for protecting both the university's IP rights and the commercial value of the research.

Does a Knowledge Transfer Partnership (KTP) require an NDA?

A KTP agreement between a university and a business partner includes Innovate UK standard terms that address IP ownership and confidentiality within the formal partnership. However, the pre-KTP scoping and negotiation phase — during which the university and the business partner discuss the proposed project, share preliminary research findings, assess technical feasibility and agree commercial terms — takes place before the KTP agreement is executed. An NDA is appropriate to cover this pre-contract phase. The same applies to Knowledge Transfer Network (KTN) brokered collaborations and Innovate UK project discussions: the formal grant agreement addresses in-project confidentiality, but pre-application discussions about research capability, commercial data and proposed deliverables benefit from a standalone NDA.

What NDA does a UK university spin-out need before investor discussions?

A university spin-out disclosing pre-commercialisation technology, laboratory results, prototype performance data, clinical evidence or patented and patent-pending IP to a potential angel investor, venture capital firm or strategic corporate partner needs an NDA before the first substantive discussion. The spin-out's founding technology is typically its primary commercial asset — an unprotected disclosure of that technology before a patent application is filed may destroy novelty; an unprotected disclosure after filing may reduce the scope of protectable claims if the investor uses the information to design around the patent. A one-way NDA (disclosing) is appropriate for investor pitches where only the spin-out is disclosing; a mutual NDA is right where the investor or corporate partner is also sharing confidential information (due diligence findings, strategic plans or portfolio company data).

Can a university NDA protect pre-patent research and invention disclosures?

Yes — and an NDA is essential in this context. If a university researcher discloses an invention to an industry partner, potential licensee or investor before a patent application is filed, that disclosure may constitute prior art and prevent a valid UK or European patent from being granted. An NDA creates a contractual obligation of confidentiality that — while it does not make the disclosure a confidential prior art disclosure exempt from novelty assessment under the European Patent Convention — provides a contractual remedy against misuse and signals to courts that the disclosure was made in confidence. Universities with active technology transfer offices typically require a signed NDA before any undisclosed invention is discussed with external parties. The NDA should include an explicit prohibition on the recipient filing any patent application based on or derived from the disclosed invention.

Do visiting researchers and academic collaborators at UK universities need to sign an NDA?

Yes, where they will have access to unpublished research data, pre-patent IP, confidential datasets or commercially sensitive research partnerships. A visiting academic from another institution is not an employee of the host university and does not automatically owe the same confidentiality obligations that would apply to an employed researcher. Similarly, a PhD student who is co-supervised across institutions, a postdoctoral researcher funded by an industry partner, or an academic consultant brought in to peer-review a grant application may all receive confidential information without clear contractual obligations unless a standalone NDA is in place. University research offices typically require visiting researchers and external academic collaborators to sign the institution's standard confidentiality agreement before accessing sensitive research data or pre-publication manuscripts.

Templates mentioned in this guide